← Back to Patent Explorer
US6280437B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Laser ablation device

Assignee: Edwards Lifesciences Corp
•
Filing: 2000-08-31
•
Granted: 2001-08-28
•
Expires: 2020-08-31
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A controlled advancement laser ablation device is provided for precise ablation of body matter. The laser ablation device includes a laser energy transmission mechanism such as, e.g., a fiber optic fiber mounted for controlled translational longitudinal movement relative to a housing structure. A laser energy generator is optically connected to the laser energy transmission mechanism. A controlled advancement mechanism is provided in engagement with the laser energy transmission mechanism for advancing the mechanism through the housing structure at a controlled rated coordinated with the laser energy generator output to ablate body tissue. Controlled advancement mechanisms include constant and/or variable rate springs, motors, and other mechanisms which can be coordinated with the laser energy generator to advance the laser energy transmission mechanism as the targeted substance is ablated. The device is particularly suitable for use in transmyocardial revascularization (TMR) and angioplasty procedures.

Inventors

  • 👤 Thomas J. Pacala
  • 👤 James Correia
  • 👤 Michael S. Kolesa
  • 👤 Oleg Shikhman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 09:55
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B17/00; A61B2017/00017; A61B2017/00137; A61B2017/00154; A61B2017/00181; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B2017/00681; A61B2017/00694; A61B2017/00703; A61B17/22; A61B2017/22072; A61B2017/22074; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00392

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 86 words
A method of ablating body matter with a laser comprising a. providing a laser energy source; b. providing at least one optical fiber having proximal and distal ends; c. disposing the optical fiber distal end adjacent body matter; d. directing laser energy through the optical fiber to ablate the body matter; and e. automatically advancing the optical fiber into the body matter at a rate that is coordinated with the power level and the frequency of the laser energy; wherein steps d and e occur simultaneously.
Claim 2
Independent Claim 86 words
A method of ablating body matter with a laser comprising a. providing a laser energy source; b. providing at least one optical fiber having proximal and distal ends; c. disposing the optical fiber distal end adjacent body matter; d. directing laser energy through the optical fiber to ablate the body matter; and e. automatically advancing the optical fiber into the body matter at a rate that is coordinated with the power level and the frequency of the laser energy; wherein steps d and e occur simultaneously.
Claim 3
Dependent Claim 24 words
The method according to claim 1 wherein the optical fiber is advanced at a rate less than the ablation rate of the body matter.
Claim 4
Dependent Claim 24 words
The method according to claim 1 wherein the optical fiber is advanced at a rate greater than the ablation rate of the body matter.
Claim 5
Independent Claim 95 words
A method of performing transmyocardial revascularization comprising: a. providing a xenon-chloride excimer laser energy source; b. providing at least one optical fiber having proximal and distal ends; c. disposing the optical fiber distal end adjacent heart tissue; d. transmitting laser energy through the optical fiber to ablate the heart tissue, the laser energy being transmitted at a power level of between about 10 mj/mm 2 and about 60 mj/mm 2 ; and e. automatically advancing the optical fiber into the heart tissue at a constant rate of between about 0.05 mm/sec to about 12 mm/sec.
Claim 6
Independent Claim 95 words
A method of performing transmyocardial revascularization comprising: a. providing a xenon-chloride excimer laser energy source; b. providing at least one optical fiber having proximal and distal ends; c. disposing the optical fiber distal end adjacent heart tissue; d. transmitting laser energy through the optical fiber to ablate the heart tissue, the laser energy being transmitted at a power level of between about 10 mj/mm 2 and about 60 mj/mm 2 ; and e. automatically advancing the optical fiber into the heart tissue at a constant rate of between about 0.05 mm/sec to about 12 mm/sec.
Claim 7
Dependent Claim 24 words
The method according to claim 1 wherein the optical fiber is advanced at a rate equal to the ablation rate of the body matter.

References Cited (Backward Citations)

US5733277A Cited
WO1996002276A2 Cited
US5766164A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2004-08-27 2005-02-26 2005-08-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2008-08-27 2009-02-26 2009-08-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2012-08-27 2013-02-26 2013-08-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag